Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer.
Valdés-Mora F, Gould CM, Colino-Sanguino Y, Qu W, Song JZ, Taylor KM, Buske FA, Statham AL, Nair SS, Armstrong NJ, Kench JG, Lee KML, Horvath LG, Qiu M, Ilinykh A, Yeo-Teh NS, Gallego-Ortega D, Stirzaker C, Clark SJ.
Valdés-Mora F, et al. Among authors: kench jg.
Nat Commun. 2017 Nov 7;8(1):1346. doi: 10.1038/s41467-017-01393-8.
Nat Commun. 2017.
PMID: 29116202
Free PMC article.